<code id='DF960BE7D9'></code><style id='DF960BE7D9'></style>
    • <acronym id='DF960BE7D9'></acronym>
      <center id='DF960BE7D9'><center id='DF960BE7D9'><tfoot id='DF960BE7D9'></tfoot></center><abbr id='DF960BE7D9'><dir id='DF960BE7D9'><tfoot id='DF960BE7D9'></tfoot><noframes id='DF960BE7D9'>

    • <optgroup id='DF960BE7D9'><strike id='DF960BE7D9'><sup id='DF960BE7D9'></sup></strike><code id='DF960BE7D9'></code></optgroup>
        1. <b id='DF960BE7D9'><label id='DF960BE7D9'><select id='DF960BE7D9'><dt id='DF960BE7D9'><span id='DF960BE7D9'></span></dt></select></label></b><u id='DF960BE7D9'></u>
          <i id='DF960BE7D9'><strike id='DF960BE7D9'><tt id='DF960BE7D9'><pre id='DF960BE7D9'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:1744
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          UnitedHealth, Optum discontinue NaviHealth name
          UnitedHealth, Optum discontinue NaviHealth name

          MarkLennihan/APUnitedHealthGroupandOptumaregettingridofthenameoftheirtech-drivencaremanagementcompan

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          HHS leader on health, climate change and biopharma emissions

          ReneeSalas,M.D.,emergencymedicinephysician,CenterforSocialJusticeandHealthEquity,departmentofemergen